Strongman, H. ., D’Oca, K. ., Langerman, H. ., & Das, R. . (2015). Comparison of diabetes-associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12458
H. Strongman
First name
H.
Last name
Strongman
Korhonen, P. ., Heintjes, E. M., Williams, R. ., Hoti, F. ., Christopher, S. ., Majak, M. ., … Bahmanyar, S. . (2016). Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries. Bmj. http://doi.org/10.1136/bmj.i3903
Strongman, H. ., Korhonen, P. ., Williams, R. ., Bahmanyar, S. ., Hoti, F. ., Christopher, S. ., … Heintjes, E. M. (2017). Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2016-000364
Chidwick, K. ., Strongman, H. ., Matthews, A. ., Stanway, S. ., Lyon, A. R., Smeeth, L. ., & Bhaskaran, K. . (2018). Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK clinical practice research datalink. BMC Cancer. http://doi.org/10.1186/s12885-018-4947-8
Strongman, H. ., Christopher, S. ., Majak, M. ., Williams, R. ., Bahmanyar, S. ., Linder, M. ., … Hoti, F. . (2018). Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2017-000481
Strongman, H. ., Kausar, I. ., & Maher, T. M. (2018). Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK. Adv Ther. http://doi.org/10.1007/s12325-018-0693-1
Padmanabhan, S. ., Carty, L. ., Cameron, E. ., Ghosh, R. E., Williams, R. ., & Strongman, H. . (2018). Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications. Eur J Epidemiol. http://doi.org/10.1007/s10654-018-0442-4
Strongman, H. ., Gadd, S. ., Matthews, A. ., Mansfield, K. E., Stanway, S. ., Lyon, A. R., … Bhaskaran, K. . (2019). Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. Lancet. http://doi.org/10.1016/s0140-6736(19)31674-5
Strongman, H. ., Williams, R. ., Meeraus, W. ., Murray-Thomas, T. ., Campbell, J. ., Carty, L. ., … Valentine, J. . (2019). Limitations for health research with restricted data collection from UK primary care. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4765
Carreira, H. ., Williams, R. ., Strongman, H. ., & Bhaskaran, K. . (2019). Identification of mental health and quality of life outcomes in primary care databases in the UK: a systematic review. BMJ Open. http://doi.org/10.1136/bmjopen-2019-029227